Latest news
Tarsus Strikes Up to $800M Deal for Alkeus, Entering Heated Stargardt Disease Race - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 18:41:00 GMTEarnings call transcript: Tarsus beats revenue in Q2 2026, but EPS miss weighs on shares - Investing.com CanadaInvesting.com Canada · Fri, 07 Aug 2026 02:02:21 GMTTarsus Bets Up To $800M On Alkeus In Retina Therapy Push - Law360Law360 · Thu, 06 Aug 2026 20:43:00 GMTAlkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 19:14:51 GMTTarsus Adds Alkeus In Up To $800 Million Deal - FinimizeFinimize · Thu, 06 Aug 2026 14:08:05 GMTTarsus bets $450M on Alkeus’ Stargardt drug - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 12:57:00 GMT